1 Market Overview
1.1 Product Overview and Scope of Hybrid Closed-Loop lnsulin Delivery System
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Type 1 Hybrid Closed Loop System
1.3.3 Type 2 Hybrid Closed Loop System
1.4 Market Analysis by Application
1.4.1 Overview: Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Private
1.4.4 Others
1.5 Global Hybrid Closed-Loop lnsulin Delivery System Market Size & Forecast
1.5.1 Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (2018-2029)
1.5.3 Global Hybrid Closed-Loop lnsulin Delivery System Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Medtronic Inc.
2.1.1 Medtronic Inc. Details
2.1.2 Medtronic Inc. Major Business
2.1.3 Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Product and Services
2.1.4 Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Inc. Recent Developments/Updates
2.2 Insulet Corporation
2.2.1 Insulet Corporation Details
2.2.2 Insulet Corporation Major Business
2.2.3 Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Product and Services
2.2.4 Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Insulet Corporation Recent Developments/Updates
2.3 Beta Bionics
2.3.1 Beta Bionics Details
2.3.2 Beta Bionics Major Business
2.3.3 Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Product and Services
2.3.4 Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beta Bionics Recent Developments/Updates
2.4 EliLilly
2.4.1 EliLilly Details
2.4.2 EliLilly Major Business
2.4.3 EliLilly Hybrid Closed-Loop lnsulin Delivery System Product and Services
2.4.4 EliLilly Hybrid Closed-Loop lnsulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 EliLilly Recent Developments/Updates
2.5 WaveForm (AgaMatrix)
2.5.1 WaveForm (AgaMatrix) Details
2.5.2 WaveForm (AgaMatrix) Major Business
2.5.3 WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Product and Services
2.5.4 WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 WaveForm (AgaMatrix) Recent Developments/Updates
2.6 Bigfoot Biomedical
2.6.1 Bigfoot Biomedical Details
2.6.2 Bigfoot Biomedical Major Business
2.6.3 Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Product and Services
2.6.4 Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bigfoot Biomedical Recent Developments/Updates
2.7 Tandem Inc.
2.7.1 Tandem Inc. Details
2.7.2 Tandem Inc. Major Business
2.7.3 Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Product and Services
2.7.4 Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Tandem Inc. Recent Developments/Updates
3 Competitive Environment: Hybrid Closed-Loop lnsulin Delivery System by Manufacturer
3.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Manufacturer (2018-2023)
3.3 Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hybrid Closed-Loop lnsulin Delivery System by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hybrid Closed-Loop lnsulin Delivery System Manufacturer Market Share in 2022
3.4.2 Top 6 Hybrid Closed-Loop lnsulin Delivery System Manufacturer Market Share in 2022
3.5 Hybrid Closed-Loop lnsulin Delivery System Market: Overall Company Footprint Analysis
3.5.1 Hybrid Closed-Loop lnsulin Delivery System Market: Region Footprint
3.5.2 Hybrid Closed-Loop lnsulin Delivery System Market: Company Product Type Footprint
3.5.3 Hybrid Closed-Loop lnsulin Delivery System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hybrid Closed-Loop lnsulin Delivery System Market Size by Region
4.1.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Region (2018-2029)
4.1.2 Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Region (2018-2029)
4.1.3 Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Region (2018-2029)
4.2 North America Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029)
4.3 Europe Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029)
4.4 Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029)
4.5 South America Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029)
4.6 Middle East and Africa Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2029)
5.2 Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Type (2018-2029)
5.3 Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2029)
6.2 Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Application (2018-2029)
6.3 Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Application (2018-2029)
7 North America
7.1 North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2029)
7.2 North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2029)
7.3 North America Hybrid Closed-Loop lnsulin Delivery System Market Size by Country
7.3.1 North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2018-2029)
7.3.2 North America Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2029)
8.2 Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2029)
8.3 Europe Hybrid Closed-Loop lnsulin Delivery System Market Size by Country
8.3.1 Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2018-2029)
8.3.2 Europe Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Market Size by Region
9.3.1 Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2029)
10.2 South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2029)
10.3 South America Hybrid Closed-Loop lnsulin Delivery System Market Size by Country
10.3.1 South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2018-2029)
10.3.2 South America Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Market Size by Country
11.3.1 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Hybrid Closed-Loop lnsulin Delivery System Market Drivers
12.2 Hybrid Closed-Loop lnsulin Delivery System Market Restraints
12.3 Hybrid Closed-Loop lnsulin Delivery System Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Hybrid Closed-Loop lnsulin Delivery System and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hybrid Closed-Loop lnsulin Delivery System
13.3 Hybrid Closed-Loop lnsulin Delivery System Production Process
13.4 Hybrid Closed-Loop lnsulin Delivery System Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hybrid Closed-Loop lnsulin Delivery System Typical Distributors
14.3 Hybrid Closed-Loop lnsulin Delivery System Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Medtronic Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Inc. Major Business
Table 5. Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Product and Services
Table 6. Medtronic Inc. Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Medtronic Inc. Recent Developments/Updates
Table 8. Insulet Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Insulet Corporation Major Business
Table 10. Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Product and Services
Table 11. Insulet Corporation Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Insulet Corporation Recent Developments/Updates
Table 13. Beta Bionics Basic Information, Manufacturing Base and Competitors
Table 14. Beta Bionics Major Business
Table 15. Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Product and Services
Table 16. Beta Bionics Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Beta Bionics Recent Developments/Updates
Table 18. EliLilly Basic Information, Manufacturing Base and Competitors
Table 19. EliLilly Major Business
Table 20. EliLilly Hybrid Closed-Loop lnsulin Delivery System Product and Services
Table 21. EliLilly Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. EliLilly Recent Developments/Updates
Table 23. WaveForm (AgaMatrix) Basic Information, Manufacturing Base and Competitors
Table 24. WaveForm (AgaMatrix) Major Business
Table 25. WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Product and Services
Table 26. WaveForm (AgaMatrix) Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. WaveForm (AgaMatrix) Recent Developments/Updates
Table 28. Bigfoot Biomedical Basic Information, Manufacturing Base and Competitors
Table 29. Bigfoot Biomedical Major Business
Table 30. Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Product and Services
Table 31. Bigfoot Biomedical Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bigfoot Biomedical Recent Developments/Updates
Table 33. Tandem Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Tandem Inc. Major Business
Table 35. Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Product and Services
Table 36. Tandem Inc. Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Tandem Inc. Recent Developments/Updates
Table 38. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Hybrid Closed-Loop lnsulin Delivery System Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Hybrid Closed-Loop lnsulin Delivery System, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Hybrid Closed-Loop lnsulin Delivery System Production Site of Key Manufacturer
Table 43. Hybrid Closed-Loop lnsulin Delivery System Market: Company Product Type Footprint
Table 44. Hybrid Closed-Loop lnsulin Delivery System Market: Company Product Application Footprint
Table 45. Hybrid Closed-Loop lnsulin Delivery System New Market Entrants and Barriers to Market Entry
Table 46. Hybrid Closed-Loop lnsulin Delivery System Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Hybrid Closed-Loop lnsulin Delivery System Raw Material
Table 106. Key Manufacturers of Hybrid Closed-Loop lnsulin Delivery System Raw Materials
Table 107. Hybrid Closed-Loop lnsulin Delivery System Typical Distributors
Table 108. Hybrid Closed-Loop lnsulin Delivery System Typical Customers
List of Figures
Figure 1. Hybrid Closed-Loop lnsulin Delivery System Picture
Figure 2. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Type in 2022
Figure 4. Type 1 Hybrid Closed Loop System Examples
Figure 5. Type 2 Hybrid Closed Loop System Examples
Figure 6. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Private Examples
Figure 10. Others Examples
Figure 11. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Hybrid Closed-Loop lnsulin Delivery System Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Hybrid Closed-Loop lnsulin Delivery System by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Hybrid Closed-Loop lnsulin Delivery System Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Hybrid Closed-Loop lnsulin Delivery System Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Hybrid Closed-Loop lnsulin Delivery System Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Region (2018-2029)
Figure 53. China Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Hybrid Closed-Loop lnsulin Delivery System Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Hybrid Closed-Loop lnsulin Delivery System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Hybrid Closed-Loop lnsulin Delivery System Market Drivers
Figure 74. Hybrid Closed-Loop lnsulin Delivery System Market Restraints
Figure 75. Hybrid Closed-Loop lnsulin Delivery System Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Hybrid Closed-Loop lnsulin Delivery System in 2022
Figure 78. Manufacturing Process Analysis of Hybrid Closed-Loop lnsulin Delivery System
Figure 79. Hybrid Closed-Loop lnsulin Delivery System Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source

※参考情報 ハイブリッド式閉ループインスリン送達装置は、糖尿病患者にとって非常に革新的なインスリン管理技術です。この技術は、血糖値の変動に対して自動的にインスリンを供給することにより、患者の生活品質を向上させ、合併症のリスクを軽減することを目的としています。 ハイブリッド式閉ループインスリン送達装置は、基本的には血糖モニタリングシステムとインスリンポンプを組み合わせたもので、リアルタイムで血糖値を自動的に測定し、その情報に基づいてインスリンを調整・供給します。このシステムの「ハイブリッド」という名称は、完全自動ではなく、一部にはユーザーの手動に依存している点を示しています。このため、患者は血糖値の管理において一定の関与が必要ですが、その負担は大幅に軽減されます。 具体的には、ハイブリッド式閉ループインスリン送達装置は主に次のような特徴を持っています。まず、血糖センサーがリアルタイムで血糖値を測定します。このセンサーは、組み込まれたカテーテルを介して皮下に挿入され、血糖値を連続的に取得します。次に、そのデータがインスリンポンプに送信され、ポンプは設定されたアルゴリズムに基づいて自動的にインスリンを投与します。このプロセスにより、患者は血糖値の変動をより効率的に管理できるようになります。 ハイブリッド式閉ループインスリン送達装置は、特に1型糖尿病患者にとって重要なツールです。この病状では、膵臓がインスリンを分泌できないため、患者は外部からインスリンを補充する必要があります。従来のインスリン療法は、患者が頻繁に血糖値を測定し、その値に応じて自らインスリンを自己注射するというものでしたが、これには高い自己管理能力が求められます。 そのため、ハイブリッド式閉ループインスリン送達装置は、患者の生活を簡素化する手段として注目を集めています。特に、夜間や運動中など、血糖が変動しやすい状況での自動調整機能が大きな利点です。また、糖尿病患者はしばしば低血糖や高血糖のリスクにさらされており、この装置はそれらのリスクを軽減する手助けを提供します。患者は、インスリンの投与を完全にコントロールしなければならないストレスから解放され、より自由な生活が可能になります。 さらに、ハイブリッド式閉ループインスリン送達装置には、さまざまな種類があります。例えば、異なるアルゴリズムを利用するデバイスや、異なる形式のセンサーとポンプを組み合わせたものが存在します。また、最近ではスマートフォンアプリと連携できるものもあり、データの視覚化やさらなる分析を行うことが可能です。このように、各デバイスはそれぞれのニーズに応じて特化されており、患者が自分に最も適したものを選ぶことができます。 用途としては、主に1型糖尿病を持つ患者に対して使われることが多いですが、2型糖尿病の一部患者にも適応可能です。特に、インスリン治療を受けているが血糖管理が難しいと感じている患者にとって、有効な選択肢となり得ます。 関連技術としては、血糖センサーの向上、アルゴリズムの改善、さらにはデジタルヘルス技術などが挙げられます。特に、デジタル技術の進展は、患者が自己管理を行いやすくするためのサポートとして非常に重要です。スマートフォンやウェアラブルデバイスとの連携により、患者は自分の健康状態をより正確に把握し、適切な判断を下すことができるようになっています。 ハイブリッド式閉ループインスリン送達装置の今後の展望としては、より自動化が進む完全閉ループシステムの実現が期待されています。これは、患者がインスリンの投与をさらに容易に行えるようにするもので、多くの関心を集めています。また、さらなる研究と技術革新が進めば、様々なタイプの糖尿病患者に対する適応が広がり、より多くの人々がこの革新から恩恵を受ける可能性があります。 総じて、ハイブリッド式閉ループインスリン送達装置は、糖尿病管理における革新であり、患者にとっての生活品質の向上だけでなく、合併症リスクの軽減にも寄与する重要な技術です。今後の発展に期待しつつ、患者にとってより良い治療環境が整備されることを願っています。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/